Lipopolysaccharides (LPS) Antikörper

Produktnummer ABIN479062

Dieses Ziege Polyklonal-Antikörper erkennt spezifisch Lipopolysaccharides (LPS) in IF. Er zeigt eine Reaktivität gegenüber Gram-negative Bakterien und wurde in 4+ Publikationen erwähnt.

Kurzübersicht für Lipopolysaccharides (LPS) Antikörper (ABIN479062)

Target: Lipopolysaccharides (LPS)

Reaktivität: Gram-negative Bakterien

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser Lipopolysaccharides (LPS) Antikörper ist unkonjugiert

Applikation: Immunofluorescence (IF)

Produktdetails anti-Lipopolysaccharides (LPS) Antikörper

Spezifität: Recognizes LPS. Cross-reactive with numerous members of the Enterobacteriaciae: Pseudomonas aeruginosa, Klebsiella pneumoniae, E. coli O157, Salmonella enteriditis, Enterobacter aerogenes, E. hermanii, Yersinia enterocolitica and Shigella sonnei.

Aufreinigung: Ion exchange chromatography

Immunogen: Whole cell prep of Lipid A from E. coli O157.

Type of Immunogen: Cells

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: IF

Usage: Suitable for use in Immunofluorescence. Tested with whole organisms in IF.

Kommentare:

Target Species of Antibody: Gram Negative Bacteria

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS,  pH 7.2, 0.09 % sodium azide. No stabilizing proteins added.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: avoid freeze thaw cycles. Store undiluted.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles. Store undiluted.

Referenzen für anti-Lipopolysaccharides (LPS) Antikörper (ABIN479062)

Marconato, Tiraboschi, Aralla, Sabattini, Melacarne, Agnoli, Balboni, Salvi, Foglia, Punzi, Romagnoli, Rescigno: "A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy." in: Cancers, Vol. 15, Issue 17, (2023) (PubMed).

Marconato, Melacarne, Aralla, Sabattini, Tiraboschi, Ferrari, Zeira, Balboni, Faroni, Guerra, Pisoni, Ghezzi, Pettinari, Rescigno: "A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy." in: Cancers, Vol. 14, Issue 5, (2022) (PubMed).

Stromberg, Stromberg, Banisadr, Graves, Moxley, Mukundan: "Purification and characterization of lipopolysaccharides from six strains of non-O157 Shiga toxin-producing Escherichia coli." in: Journal of microbiological methods, Vol. 116, pp. 1-7, (2015) (PubMed).

Zaborin, Defazio, Kade, Kaiser, Belogortseva, Camp, Smith, Adkins, Kim, Alverdy, Goldfeld, Firestone, Collier, Jabri, Tirrell, Zaborina, Alverdy: "Phosphate-containing polyethylene glycol polymers prevent lethal sepsis by multidrug-resistant pathogens." in: Antimicrobial agents and chemotherapy, Vol. 58, Issue 2, pp. 966-77, (2014) (PubMed).

Details zu Lipopolysaccharides (LPS)

Target: Lipopolysaccharides (LPS)

Andere Bezeichnung: Lipopolysaccharide / LPS

Substanzklasse: Chemical

Hintergrund: Name/Gene ID: LPS

Synonyms: LPS